Akanda Corp. (AKAN)
NASDAQ: AKAN · IEX Real-Time Price · USD
2.000
-0.140 (-6.54%)
At close: Jul 19, 2024, 4:00 PM
2.050
+0.050 (2.50%)
Pre-market: Jul 22, 2024, 7:15 AM EDT
Akanda Revenue
In the year 2023, Akanda had annual revenue of $2.16M.
Revenue (ttm)
$2.16M
Revenue Growth
-17.55%
P/S Ratio
1.77
Revenue / Employee
$46,958
Employees
46
Market Cap
3.83M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.16M | -459.63K | -17.55% |
Dec 31, 2022 | 2.62M | 2.58M | 6,223.00% |
Dec 31, 2021 | 41.43K | 39.37K | 1,909.26% |
Dec 31, 2020 | 2.06K | - | - |
Dec 31, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Regional Health Properties | 17.39M |
iSpecimen | 9.27M |
China Pharma Holdings | 6.42M |
Sintx Technologies | 2.78M |
OpGen | 2.67M |
AKAN News
- 5 weeks ago - Akanda Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement - Newsfile Corp
- 5 weeks ago - Akanda Corporation Announces Completion of F-3 Shelf Registration Statement - Newsfile Corp
- 2 months ago - Akanda Announces Stock Consolidation - Newsfile Corp
- 2 months ago - Akanda Announces Closing of Subsequent Registered Direct Offering - Newsfile Corp
- 2 months ago - Akanda Corp. Announces Subsequent Registered Direct Offering - Newsfile Corp
- 2 months ago - Akanda Announces Closing of Registered Direct Offering - Newsfile Corp
- 2 months ago - Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 2 months ago - Akanda Corp receives non-compliance notice from Nasdaq - Invezz